Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.


Primary Biliary Cholangitis (PBC) is a chronic autoimmune disease of the liver. In PBC, the small bile ducts in the liver are damaged by an autoimmune process. If PBC is not treated, permanent liver damage can occur, so that the liver can only perform its important tasks for the entire organism to a limited extent or not at all.

There is little data on the quality of life of PBC patients. There is also a lack of data on which self-management strategies reduce the burden of symptoms and thus have a positive impact on quality of life.

A questionnaire was developed based on existing validated questionnaires.

In a first survey (2017-2019) 580 answers could be collected.

In a second survey, an adapted questionnaire was used (use of the PBC 10 and SF12; coordination and pre-test with cooperating centers; Deutsche Leberhilfe e.V. and statisticians). Almost 1000 responses have been collected so far.

Our cooperation partners in this project are: Andreas Kremer, Christian Trautwein, Carsten Schwenke and the Deutsche Leberhilfe e.V.

We gratefully received support from Intercept Pharma.

Other orders and projects that resulted from this were the abstract itching, a QoL presentation at the DGEM 2019 congress and an abstract at the DGVS conference 2019. Further publications are also in preparation.

Copyright 2024 Kautzāµ. All Rights Reserved.
You are using an outdated browser. The website may not be displayed correctly. Close